Reproductive Medicine Associates of New Jersey (http://www.rmanj.com) today presented interim findings from its BEST (Blastocyst Euploid Selective Transfer) trial, the first well-controlled clinical trial comparing in vitro fertilization (IVF) pregnancy rates in a group of women receiving a single embryo transfer (SET) with comprehensive chromosome screening (CCS) with a group receiving traditional morphology-based double embryo transfer (DET). The findings were presented at the American Society for Reproductive Medicine 68th Annual Meeting in San Diego, October 20-24, 2012.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58883-rmanj-best-trial-results-ivf-pregnancy-rates-women-asrm-annual-meeting
VolAero Drones is working with famed outdoorsman Bill Booth to demonstrate that drones equipped with the latest thermal imaging equipment can effectively spot and track pythons at night – the prime hunting time. Over 100,000 Burmese pythons infesting the Florida Everglades have decimated 90 percent of small wildlife while surviving all attempts at eradication.
“Python hunters finally have a tool to make hunting more efficient, bringing down the python numbers that are devastating Florida’s Everglades,” said Booth. “This drone and thermal technology is light-years ahead of shining a flashlight into the darkness and hoping for the best. The thermal imagery picked up not just the monster pythons, but also native snakes as small as 18 inches. This suggests that we’ll be able to spot and eliminate clusters of python hatchlings, which will help curb their reproductive cycle.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8225051-volaero-drones-thermal-technology-python-invasion-everglades/
More than 15 percent of reproductive-aged women have filled a prescription for an antidepressant medication during the years 2008–2013, according to a new analysis published today in the Centers for Disease Control and Prevention (CDC)’s Morbidity and Mortality Weekly Report (MMWR).
January is National Birth Defects Prevention Month and the CDC is working with the March of Dimes to raise awareness about the use of antidepressant medications by women of reproductive age, and what women should know and do for their own health and that of their babies. There is conflicting evidence about the potential link between some antidepressants and certain birth defects. Some commonly used antidepressants are sertraline (Zoloft), bupropion (Wellbutrin, Zyban), and citalopram (Celexa).
To view the multimedia release go to:
http://www.multivu.com/players/English/7709851-march-of-dimes-antidepressant-pregnancy-study/
On September 10, 2016, the nation’s leading reproductive health, rights, and justice organizations will host free music and cultural events that shine a light on the majority of Americans who support abortion rights and show how access to abortion benefits women, their families and ultimately, the country.
All Access, a series of high-energy concerts, is bringing top musical and comedic talent to Cleveland with four other events taking place simultaneously in Atlanta, Chicago, Miami, and Philadelphia. From dance parties to slam poetry contests, thousands more will participate in more than 30 smaller events across the country to show that abortion rights supporters are visible, active, and willing to speak up.
To view the multimedia release go to:
http://www.multivu.com/players/English/7869451-all-access-concert-supporting-abortion-access/
BioPharmX Corporation (OTCQB: BPMX) today announced the availability of Violet™ iodine, a new, once-daily pill for relief of premenstrual breast discomfort. The first-of-its-kind product is based on the latest molecular iodine technology designed to help free women from the burden of breast discomfort by addressing the underlying causes of a condition known as fibrocystic breast condition (FBC), with the added benefit of promoting breast health for women of reproductive age.*
*These statements have not been evaluated by the U.S. Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7378951-biopharmx-introducing-violet-iodine-premenstrual-breast-discomfort/
The complete solution to managing vaginal dryness and discomfort inside and out is now available to the millions of women changing physically, emotionally and hormonally every day. The maker of #1 doctor recommended Replens™ vaginal moisturizer introduces hormone-free and fragrance-free Replens™ Moisture Restore External Comfort Gel, for soothing relief from external vaginal dryness, in menopause, post-partum, and after a cancer diagnosis.
“Ladies, don’t despair. Vaginal dryness can be a nuisance at any age. It’s one of the most common symptoms of menopause and unfortunately, can worsen over time. Luckily, there are non-hormonal products like Replens,” says Mary Jane Minkin, M.D., Clinical Professor of Obstetrics, Gynecology and Reproductive Sciences at Yale University. “I recommend these products to patients as first line therapies to help relieve internal and external vaginal dryness.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8066251-replens-vaginal-moisture-restore-external-comfort-gel/
